A model international partnership for community-based research on vaccine-preventable diseases: The Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU)

Vaccine

Volumn 31, Issue 41, 2013, Pages 4487-4500

  Gibbons, Robert V ^a   Nisalak, Ananda ^a   Yoon, In Kyu ^a   Tannitisupawong, Darunee ^a   Rungsimunpaiboon, Kamchai ^b   Vaughn, David W ^c   Endy, Timothy P ^d   Innis, Bruce L ^e   Burke, Donald S ^f   Mammen, Mammen P ^g   Scott, Robert McNair ^h   Thomas, Stephen J ⁱ   Hoke, Charles H ^h  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Kamphaeng Phet Provincial Hospital   (Thailand)

^c GSK   (Belgium)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g VICAL INC   (United States)

^h Walter Reed Army Institute of Research ^*

ⁱ WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Collaboration; Dengue vaccine; Hepatitis A vaccine; Influenza; Japanese encephalitis vaccine; Public Health; Site selection; Team building; Vaccine efficacy trials

Indexed keywords

DENGUE VACCINE; HEPATITIS A VACCINE; IMMUNOGLOBULIN M ANTIBODY; JAPANESE ENCEPHALITIS VACCINE;

CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COMMUNITY ASSESSMENT; DENGUE; DENGUE VIRUS; DRUG EFFICACY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG SAFETY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLU LIKE SYNDROME; HEMORRHAGIC FEVER; HEPATITIS; HEPATITIS A VIRUS; HISTORY; HOSPITAL; HUMAN; INCIDENCE; INFLUENZA VIRUS; INTERNATIONAL COOPERATION; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MEDICAL SOCIETY; MORBIDITY; NONBIOLOGICAL MODEL; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH PROBLEM; PUBLICATION; REVIEW; STANDARDIZATION; THAILAND; UNITED STATES; UNIVERSITY; VACCINATION; ZOOLOGY;

COLLABORATION; DENGUE VACCINE; HEPATITIS A VACCINE; INFLUENZA; JAPANESE ENCEPHALITIS VACCINE; PUBLIC HEALTH; SITE SELECTION; TEAM BUILDING; VACCINE EFFICACY TRIALS;

HUMANS; INTERNATIONAL COOPERATION; THAILAND; TREATMENT OUTCOME; UNITED STATES; VIRAL VACCINES; VIRUS DISEASES;

EID: 84883597567     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.082     Document Type: Review

References (130)

1. Woodward T.E. Introduction to the history of the Armed Forces Medical Units in Kuala Lumpur Malaya and the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok 2013, Thailand. 5 February 1987. Found at: http://www.afrims.org/weblib/eArchive/History%20of%20AFRIMS.pdf (accessed 23.02.13).
2. Gunakasem P., Chantrasri C., Simasathien P., Chaiyanun S., Jatanasen S., Pariyanonth A. Surveillance of Japanese encephalitis cases in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 1981, 12:333-337.
3. Gunakasem P., Chantrasri C., Chaiyanun S., Simasathien P., Jatanasen S., Sangpetchsong V. Surveillance of dengue hemorrhagic fever cases in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 1981, 12:338-343.
4. Jatanasen S. Occurrence of haemorrhagic fever in Thailand, 1958-64. Bulletin of the World Health Organization 1966, 35:79-80.
5. Pant C.P., Jatanasen S., Yasuno M. Prevalence of Aedes aegypti and Aedes albopictus and observations on the ecology of dengue haemorrhagic fever in several areas of Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 1973, 4:113-121.
6. Halstead S.B., Nimmannitya S., Cohen S.N. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale Journal of Biology and Medicine 1970, 42:311-328.
7. Russell P.K., Nisalak A. Dengue virus identification by the plaque reduction neutralization test. Journal of Immunology 1967, 99:291-296.
8. Russell P.K., Nisalak A., Sukhavachana P., Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. Journal of Immunology 1967, 99:285-290.
9. Russell P.K., Yuill T.M., Nisalak A., Udomsakdi S., Gould D.J., Winter P.E. An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. American Journal of Tropical Medicine and Hygiene 1968, 17:600-608.
10. Top F.T., Gunakasem P., Chantrasri C., Supavadee J. Serologic diagnosis of Dengue haemorrhagic fever using filter paper discs and one Dengue antigen. Southeast Asian Journal of Tropical Medicine and Public Health 1975, 6:18-24.
11. Nimmannitya S., Halstead S.B., Cohen S.N., Margiotta M.R. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. American Journal of Tropical Medicine and Hygiene 1969, 18:954-971.
12. Grossman R.A., Gould D.J., Smith T.J., Johnsen D.O., Pantuwatana S. Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. I. Introduction and study design. American Journal of Epidemiology 1973, 98:111-120.
13. Pearlman E.J., Doberstyn E.B., Sudsok S., Thiemanun W., Kennedy R.S., Canfield C.J. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142, 490, A 4-quinolinemethanol). American Journal of Tropical Medicine and Hygiene 1980, 29:1131-1137.
14. Gould D.J., Edelman R., Grossman R.A., Nisalak A., Sullivan M.F. Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. IV. Vector studies. American Journal of Epidemiology 1974, 100:49-56.
15. Snitbhan R., Scott R.M., Bancroft W.H., Top F.H., Chiewsilp D. Subtypes of hepatitis B surface antigen in Southeast Asia. Journal of Infectious Diseases 1975, 131:708-711.
16. Burke D.S., Nisalak A., Ussery M.A. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. Journal of Clinical Microbiology 1982, 16:1034-1042.
17. Burke D.S., Nisalak A. Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. Journal of Clinical Microbiology 1982, 15:353-361.
18. Burke D.S., Nisalak A., Ussery M.A., Laorakpongse T., Chantavibul S. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. Journal of Infectious Diseases 1985, 151:1093-1099.
19. Burke D.S., Nisalak A., Hoke C.H. Field trial of a Japanese encephalitis diagnostic kit. Journal of Medical Virology 1986, 18:41-49.
20. Burke D.S., Lorsomrudee W., Leake C.J., Hoke C.H., Nisalak A., Chongswasdi V., et al. Fatal outcome in Japanese encephalitis. American Journal of Tropical Medicine and Hygiene 1985, 34:1203-1210.
21. Grossman R.A., Edelman R., Willhight M., Pantuwatana S., Udomsakdi S. Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections. American Journal of Epidemiology 1973, 98:133-149.
22. Jacobson J.A., Hills S.L., Winkler J.L., Mammen M., Thaisomboonsuk B., Marfin A.A., Gibbons R.V. Evaluation of three immunoglobulin M antibody capture enzyme-linked immunosorbent assays for diagnosis of Japanese encephalitis. American Journal of Tropical Medicine and Hygiene 2007, 77:164-168.
23. Wierzba T.F., Ghimire P., Malla S., Banerjee M.K., Shrestha S., Mammen M.P., et al. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications of these results for a national immunization strategy. American Journal of Tropical Medicine and Hygiene 2008, 78:1002-1006.
24. Khalakdina A., Shrestha S.K., Malla S., Hills S., Thaisomboonsuk B., Shrestha B., et al. Field evaluation of commercial MAC ELISA diagnostic tests for the detection of Japanese encephalitis virus infection among encephalitis patients in Nepal. International Journal of Infectious Diseases 2010, 14(S3):e79-e84.
25. Moore C.E., Blacksell S.D., Taojaikong T., Jarman R.G., Gibbons R.V., Lee S.J., et al. A prospective assessment of the accuracy of commercial IgM ELISAs in diagnosis of Japanese encephalitis virus infections in patients with suspected central nervous system infections in Laos. American Journal of Tropical Medicine and Hygiene 2012, 87:171-178.
26. Hoke C.H., Vaughn D.W., Nisalak A., Intralawan P., Poolsuppasit S., Jongsawas V., et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. Journal of Infectious Diseases 1992, 165:631-637.
27. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. New England Journal of Medicine 1988, 319:608-614.
28. Defraites R.F., Gambel J.M., Hoke C.H., Sanchez J.L., Withers B.G., Karabatsos N., et al. Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens. American Journal of Tropical Medicine and Hygiene 1999, 61:288-293.
29. Chunsuttiwat S. Issues related to integration of JE vaccine into national EPI: experience from Thailand 1998, Department of Communicable Disease Control, Ministry of Public Health, Thailand.
30. Chunsuttiwat S Japanese encephalitis in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 1989, 20:593-597.
31. Campbell G.L., Hills S.L., Fischer M., Jacobson J.A., Hoke C.H., Hombach J.M., et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bulletin of the World Health Organization 2011, 89:766-774.
32. Innis B.L., Nisalak A., Nimmannitya S., Kusalerdchariya S., Chongswasdi V., Suntayakorn S., et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. American Journal of Tropical Medicine and Hygiene 1989, 40:418-427.
33. Lyons A., Kanesa-thasan N., Kuschner R.A., Eckels K.H., Putnak R., Sun W., et al. A phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine 2007, 25:3445-3453.
34. See Section 14: Japanese Encephalitis Vaccine, Inactivated, Adsorbed Package Inserts at (accessed 18.05.13) and (accessed 18.05.13). http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123761.pdf.
35. Vaughn D.W., Hoke C.H. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiologic Reviews 1992, 14:197-221.
36. Endy T.P., Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Current Topics in Microbiology and Immunology 2002, 267:11-48.
37. Johnson R.T., Burke D.S., Elwell M., Leake C.J., Nisalak A., Hoke C.H., Lorsomrudee W. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Annals of Neurology 1985, 18:567-573.
38. Burke D.S., Ussery M.A., Elwell M.R., Nisalak A., Leake, Laorakpongse T. Isolation of Japanese encephalitis virus strains from sentinel pigs in northern Thailand, 1982. Transactions of the Royal Society of Tropical Medicine and Hygiene 1985, 79:420-421.
39. Burke D.S., Nisalak A., Lorsomrudee W., Ussery M.A., Laorpongse T. Virus-specific antibody-producing cells in blood and cerebrospinal fluid in acute Japanese encephalitis. Journal of Medical Virology 1985, 17:283-292.
40. Leake C.J., Ussery M.A., Nisalak A., Hoke C.H., Andre R.G., Burke D.S. Virus isolations from mosquitoes collected during the 1982 Japanese encephalitis epidemic in northern Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 1986, 80:831-837.
41. Leake C.J., Burke D.S., Nisalak A., Hoke C.H. Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line. American Journal of Tropical Medicine and Hygiene 1986, 35:1045-1050.
42. Libraty D.H., Nisalak A., Endy T.P., Suntayakorn S., Vaughn D.W., Innis B.L. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2002, 96:173-178.
43. Lemon S.M., Binn L.N. Serum neutralizing antibody response to hepatitis A virus. Journal of Infectious Diseases 1983, 148:1033-1039.
44. Binn L.N., Bancroft W.H., Lemon S.M., Marchwicki R.H., LeDuc J.W., Trahan C.J., Staley E.C., Keenan C.M. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures. Journal of Infectious Diseases 1986, 153:749-756.
45. Sjogren M.H., Hoke C.H., Binn L.N., Eckels K.H., Dubois D.R., Lyde L., et al. Immunogenicity of an inactivated hepatitis A vaccine. Annals of Internal Medicine 1991, 114:470-471.
46. Hoke C.H., Binn L.N., Egan J.E., DeFraites R.F., MacArthy P.O., Innis B.L., et al. Hepatitis A in the US Army: epidemiology and vaccine development. Vaccine 1992, 10(Suppl. 1):S75-S79.
47. Innis B.L., Snitbhan R., Hoke C.H., Munindhorn W., Laorakpongse T. The declining transmission of hepatitis A in Thailand. Journal of Infectious Diseases 1991, 163:989-995.
48. Innis B.L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Suntayakorn S., et al. Field efficacy trial of inactivated hepatitis A vaccine among children in Thailand. Vaccine 1992, 10(S1):S159.
49. Innis B.L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Kozik C.A., et al. Protection against hepatitis A by an inactivated vaccine. Journal of the American Medical Association 1994, 271:1328-1334.
50. See Package Insert, Page 8, Item 14.1. http://us.gsk.com/products/assets/us_havrix.pdf.
51. Teppakdee A., Tangwitoon A., Khemasuwan D., Tangdhanakanond K., Suramaethakul N., Sriratanaban J., et al. Cost-benefit analysis of hepatitis A vaccination in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 2002, 33:118-127.
52. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries Moral standards for research in developing countries: from "reasonable availability" to "fair benefits". Hastings Center Report 2004, 34:17-27.
53. Armed Forces Health Surveillance Center (AFHSC) Hospitalizations for hepatitis A, B, and C, active component, U.S. Armed Forces, 1991-2011. MSMR 2012, 19(August):18-21.
54. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. Journal of the American Medical Association 2005, 294:202-210.
55. WHO Technical guides for diagnosis, treatment, surveillance, prevention and control of Dengue hemorrhagic fever 1975, World Health Organization, Geneva.
56. Henchal E.A., McCown J.M., Seguin M.C., Gentry M.K., Brandt W.E. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. American Journal of Tropical Medicine and Hygiene 1983, 32:164-169.
57. Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. American Journal of Tropical Medicine and Hygiene 1982, 31:830-836.
58. Gentry M.K., Henchal E.A., McCown J.M., Brandt W.E., Dalrymple J.M. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 1982, 31(3 Pt 1):548-555.
59. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002, 60:309-318.
60. Wichmann O., Yoon I., Sabchareon A., Vong S., Gibbons R.V., Mammen M.P., et al. Dengue in Thailand and Cambodia: using data from prospective cohort studies for better disease burden estimates. PLoS Neglected Tropical Diseases 2011, 5:e996.
61. Kalayanarooj S., Vaughn D.W., Nimmannitya S., Green S., Suntayakorn S., Kunentrasai N., et al. Early clinical and laboratory indicators of acute dengue illness. Journal of Infectious Diseases 1997, 176:313-321.
62. Sudiro T.M., Ishiko H., Green S., Vaughn D.W., Nisalak A., Kalayanarooj S., et al. Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. American Journal of Tropical Medicine and Hygiene 1997, 56:424-429.
63. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., et al. Dengue in the early febrile phase: viremia and antibody responses. Journal of Infectious Diseases 1997, 176:322-330.
64. Rico-Hesse R., Harrison L.M., Nisalak A., Vaughn D.W., Kalayanarooj S., Green S., et al. Molecular evolution of dengue type 2 virus in Thailand. American Journal of Tropical Medicine and Hygiene 1998, 58:96-101.
65. Mathew A., Kurane I., Green S., Stephens H.A.F., Vaughn D.W., Kalayanarooj S., et al. Predominance of HLA restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. Journal of Virology 1998, 72:3999-4004.
66. Cuzzubbo A.J., Vaughn D.W., Nisalak A., Suntayakorn S., Aaskov J., Devine P.L. Detection of specific antibodies in saliva during dengue infection. Journal of Clinical Microbiology 1998, 36:3737-3739.
67. Sudiro T.M., Ishiko H., Rothman A.L., Kershaw D.E., Green S., Vaughn D.W., et al. Microplate-reverse hybridization method to determine dengue virus serotype. Journal of Virologic Methods 1998, 73:229-235.
68. Mathew A., Kurane I., Green S., Vaughn D.W., Kalyanarooj S., Suntyakorn S., et al. Impaired T cell proliferation in acute dengue infection. Journal of Immunology 1999, 162:5607-5615.
69. Green S., Pichyangkul S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Nisalak A., et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. Journal of Infectious Diseases 1999, 180:1429-1435.
70. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. Journal of Infectious Diseases 1999, 179:755-762.
71. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. Journal of Medical Virology 1999, 59:329-334.
72. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Journal of Infectious Diseases 2000, 181:2-9.
73. Sudiro T.M., Zivny J., Ishiko H., Green S., Vaughn D.W., Kalayanarooj S., et al. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. Journal of Medical Virology 2001, 63:29-34.
74. Gagnon S.J., Leporati A., Green S., Kalayanarooj S., Vaughn D.W., Stephens H.A.F., et al. T cell receptor V®□ gene usage in Thai children with dengue virus infection. American Journal of Tropical Medicine and Hygiene 2001, 64:41-48.
75. Gagnon S.J., Mori M., Kurane I., Green S., Vaughn D.W., Kalayanarooj S., et al. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. Journal of Medical Virology 2002, 67:41-46.
76. Zivna I., Green S., Vaughn D.W., Kalayanarooj S., Stephens H.A.F., Chandanayingyong D., et al. The magnitude of T cell response to an HLAB7-restricted epitope on the dengue NS3 protein is associated with the severity of clinical disease in acute dengue virus infection. Journal of Immunology 2002, 168:5959-5965.
77. Stephens H.A.F., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting virus serotype in ethnic Thais. Tissue Antigens 2002, 60:309-318.
78. Vejbaesya S., Luangtrakool P., Luangtrakool K., Kalayanarooj S., Vaughn D.W., Endy T.P., et al. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. Journal of Infectious Diseases 2009, 199:1442-1448.
79. Srikiatkhachorn A., Gibbons R.V., Green S., Libraty D.H., Thomas S.J., Endy T.P., et al. Dengue hemorrhagic fever: the sensitivity and specificity of the WHO definition in identifying severe dengue cases in Thailand, 1994-2005. Clinical Infectious Diseases 2010, 50:1135-1143.
80. Endy T.P., Chunsuttiwat S., Nisalak A., Libraty D.H., Green S., Rothman A.L., et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. American Journal of Epidemiology 2002, 156:40-51.
81. Endy T.P., Nisalak A., Chunsuttiwat S., Libraty D.H., Green S., Rothman A.L., et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in KPP, Thailand. American Journal of Epidemiology 2002, 156:52-59.
82. Mangada M.M., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Libraty D.H., et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. Journal of Infectious Diseases 2002, 185:1697-1703.
83. Raengsakulrach B., Nisalak A., Maneekarn N., Yenchitsomanus P.T., Limsomwong C., Jairungsri A., et al. Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. Journal of Virological Methods 2002, 105:219-232.
84. Wittke V., Robb T.E., Thu H.M., Nisalak A., Nimmannitya S., Kalayanrooj S., et al. Extinction and rapid emergence of strains of dengue 3 virus during an inter-epidemic period. Virology 2002, 301:148-156.
85. Endy T.P., Nisalak A., Chunsuttitwat S., Vaughn D.W., Green S., Ennis F.A., et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. Journal of Infectious Diseases 2004, 189:990-1000.
86. Zhang C., Mammen M.P., Chinnawirotpisan P., Klungthong C., Rodpradit P., Monkongdee P., et al. Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. Journal of Virology 2005, 79:15123-15130.
87. Laoprasopwattana K., Libraty D.H., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., et al. Dengue virus (DV) enhancing antibody activity in pre-illness plasma does not predict subsequent disease severity or viremia in secondary DV infection. Journal of Infectious Diseases 2005, 192:510-519.
88. Clark D.V., Mammen M.P., Nisalak A., Puthimethee V., Endy T.P. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. American Journal of Tropical Medicine and Hygiene 2005, 72:786-791.
89. Myint K.S., Endy T.P., Mongkolsirichaikul D., Manomuth C., Kalayanarooj S., Vaughn D.W., et al. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. Journal of Infectious Diseases 2006, 194:600-607.
90. Koenraadt C.J., Tuiten W., Sithiprasasna R., Kijchalao U., Jones J.W., Scott T.W. Dengue knowledge and practices and their impact on Aedes aegypti populations in KPP, Thailand. American Journal of Tropical Medicine and Hygiene 2006, 74:692-700.
91. Anderson K.B., Chunsuttiwat S., Nisalak A., Mammen M.P., Libraty D.H., Rothman A.L., et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 2007, 369:1452-1459.
92. Libraty D.H., Myint K.S., Murray C.K., Gibbons R.V., Mammen M.P., Endy T.P., et al. A comparative study of leptospirosis and dengue in Thai children. PLoS Neglected Tropical Diseases 2007, 1:111.
93. Koenraadt C.J., Jones J.W., Sithiprasasna R., Scott T.W. Standardizing container classification for immature Aedes aegypti surveillance in KPP, Thailand. Journal of Medical Entomology 2007, 44:938-944.
94. Mammen M.P., Pimgate C., Koenraadt C.J., Rothman A.L., Aldstadt J., Nisalak A., et al. Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Medicine 2008, 5:1605-1616. [article no. e205].
95. Jarman R.G., Holmes E.C., Rodpradit P., Klungthong C., Gibbons R.V., Nisalak A., et al. Microevolution of Dengue viruses circulating among primary school children in KPP, Thailand. Journal of Virology 2008, 82:5494-5500.
96. Lambrechts L., Chevillon C., Albright R.G., Thaisomboonsuk B., Richardson J.H., Jarman R.G., et al. Genetic specificity and potential for local adaptation between dengue viruses and mosquito vectors. BMC Evolutionary Biology 2009, 9:160.
97. Van Panhuis W.G., Gibbons R.V., Endy T.P., Rothman A.L., Nisalak A., Burke D.S., et al. Inferring the serotype of dengue virus infections based on pre- and post-infection neutralizing antibody titers. Journal of Infectious Diseases 2010, 202:1002-1010.
98. Endy T.P., Yoon I.K., Mammen M.P. Prospective cohort studies of dengue viral transmission and severity of disease. Current Topics in Microbiology and Immunology 2010, 338:1-13.
99. Endy T.P., Anderson K.B., Nisalak A., Yoon I., Green S., Rothman A.L., et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in KPP, Thailand. PLoS Neglected Tropical Diseases 2011, 5:e975.
100. Anderson K., Gibbons R.V., Thomas S.J., Rothman A.L., Nisalak A., Berkelman R., et al. Pre-existing Japanese encephalitis virus (JEV) neutralizing antibodies are associated with an increased risk of symptomatic dengue (DENV) illness in a prospective cohort study of school-children in Thailand. PLoS Neglected Tropical Diseases 2011, 5:e1311.
101. Aldstadt J., Koenraadt C.J., Fansiri T., Kijchalao U., Richardson J., Jones J.W., et al. Ecological modeling of Aedes aegypti (L.) pupal production in rural KPP, Thailand. PLoS Neglected Tropical Diseases 2011, 5(1):e940.
102. Aldstadt J., Yoon I.K., Tannitisupawong D., Jarman R.G., Thomas S.J., Gibbons R.V., et al. Space-time analysis of hospitalised dengue patients in rural Thailand reveals important temporal intervals in the pattern of dengue virus transmission. Tropical Medicine and International Health 2012, 17:1076-1085.
103. Yoon I.K., Rothman A.L., Tannitisupawong D., Srikiatkhachorn A., Jarman R.G., Aldstadt J., et al. The hidden threat: mildly symptomatic viremic dengue infections in rural Thai schools and villages. JID 2012, 206:389-398.
104. Yoon I.K., Getis A., Aldstadt J., Rothman A.L., Tannitisupawong D., Koenraadt C.J.M., et al. Fine scale spatiotemporal clustering of dengue virus transmission in children and Aedes aegypti in rural Thai villages. PLoS Neglected Tropical Disease 2012, 6:e1730.
105. Anderson KB, Endy TP, Mammen MP, Greene S, Yoon IK, Gibbons RV. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a prospective school-based cohort in Thailand; [under review].
106. Rabaa M.A., Klungthong C., Yoon I.K., Holmes E.C., Chinnawirotpisan P., Thaisomboonsuk B., et al. Frequent in-migration and highly focal transmission of dengue viruses among children in KPP, Thailand. PLoS Neglected Tropical Diseases 2012, 10.1371/journal.pntd.0001990.
107. Scott T.W., Chow E., Strickman D., Kittayapong P., Wirtz R.A., Lorenz L.H., et al. Blood-feeding patterns of Aedes aegypti (Diptera: Culicidae) collected in a rural Thai village. Journal of Medical Entomology 1993, 30:922-927.
108. Solomon T., Dung N.M., Vaughn D.W., Kneen R., Thao L.T., Raengsakulrach B., et al. Neurological manifestations of dengue infection. Lancet 2000, 355:1053-1059.
109. Jones J.W., Sithiprasasna R., Schleich S., Coleman R.E. Evaluation of selected traps as tools for conducting surveillance for adult Aedes aegypti in Thailand. Journal of the American Mosquito Control Association 2003, 19:148-150.
110. Zhang C., Mammen M.P., Chinnawirotpisan P., Klungthong C., Rodpradit P., Nisalak A., et al. Structure and age of genetic diversity of dengue virus type 2 in Thailand. Journal of General Virology 2006, 87:873-883.
111. Myint K.S., Gibbons R.V., Murray C.K., Rungsimanphaiboon K., Supornpun W., Sithiprasasna R., et al. Leptospirosis in KPP, Thailand. American Journal of Tropical Medicine and Hygiene 2007, 76:135-138.
112. Gibbons R.V., Kalanarooj S., Jarman R.G., Nisalak A., Vaughn D.W., Endy T.P., et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. American Journal of Tropical Medicine and Hygiene 2007, 77:910-913.
113. Thomas SJ, Aldstadt J, Jarman RG, Tannitisupawong D, Yoon IK, Ponlawat A, et al. Dengue virus circulation and virus-vector-host interactions in KPP Province, Thailand; [in preparation].
114. Salje H., Lessler J., Endy T.P., Curriero F., Gibbons R.V., Nisalak A., et al. Revealing the micro-scale spatial signature of dengue transmission and immunity in an urban population. Proceedings of the National Academy of Science 2012, 109:9235-9238.
115. Libraty D.H., Myint K.S., Murray C.K., Gibbons R.V., Mammen M.P., Endy T.P., et al. A comparative study of leptospirosis and dengue in Thai children. PLoS Neglected Tropical Diseases 2007, 1(3):e111.
116. Pavlin J.A., Hickey A.C., Ulbrandt N., Chan Y.P., Endy T.P., Boukhvalova M.S., et al. Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. Journal of Infectious Diseases 2008, 198:836-842.
117. Burke R.L., Vest K.G., Eick A.A., et al. Department of defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health 2011, 11(S2):S6.
118. Khuntirat B.P., Yoon I.K., Blair P.J., Krueger W.S., Chittagarnpitch M., Putnam S.D., et al. Evidence for subclinical avian influenza virus infections among rural Thai villagers. Clinical Infectious Diseases 2011, 53:e107-e116.
119. Johns M.C., Burke R.L., Vest K.G., et al. A growing global network's role in outbreak response: AFHSC-GEIS 2008-2009. BMC Public Health 2011, 11(S2):S3.
120. Sanchez J.L., Johns M.C., Burke R.L., et al. Capacity-building efforts by the AFHSC-GEIS program. BMC Public Health 2011, 11(S2):S4.
121. Sabin A.B. Epidemic encephalitis in military personnel; isolation of Japanese B virus on Okinawa in 1945, serologic diagnosis, clinical manifestations, epidemiologic aspects and use of mouse brain vaccine. Journal of the American Medical Association 1947, 133:281-293.
122. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. New England Journal of Medicine 2007, 356:895-903.
123. Myint K.S., Endy T.P., Shrestha M.P., Shrestha S.K., Vaughn D.W., Innis B.L., et al. Hepatitis E antibody kinetics in Nepalese patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006, 100:938-941.
124. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine 2009, 361:2209-2220.
125. Muangchana C., Henprasertthae N., Nurach K., Theppang K., Yoocharoen P., Varinsathien P., et al. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study. Vaccine 2012, 30:361-367.
126. Siraprapasiri T., Sawaddiwudhipong W., Rojanasuphot S. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 1997, 28:143-148.
127. Communication provided by Dr. Bruce Innis "The last time I was in KPP was 2006. I went looking to purchase some wine for a dinner. The attendant in the store was a young adult, around 25 years of age. We chatted about why I was in KPP and I explained I was escorting colleagues who were considering the feasibility of a dengue vaccine study in KPP. She said she had been in a hepatitis vaccine project 15 years earlier and I explained that I knew something about that and moreover, because of that study, a new vaccine was licensed for use globally. She was pleased, but much more interested to meet one of the foreigners who helped initiate the trial in her youth and to know that perhaps there would be another field trial someday concerning dengue. I was struck by her recall - that hepatitis trial made an impression on her (and me too)! I suppose the same is true for participants in all of the major multi-year cohort studies involving children there.".
128. (accessed 26.06.13). http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html.
129. Tuckman B.W. Developmental sequence in small groups. Psychological Bulletin 1965, 63:384-399.
130. Russell P.K. Excellence in research is not enough. American Journal of Tropical Medicine and Hygiene 1984, 33:319-324.